Menu Menu

Amy Banes-Berceli


Amy Banes-Berceli
Assistant Professor, Ph.D.
307 SEB
(248) 370-4906
Lab Location: 310 SEB
Lab Phone: 3592
banesber@oakland.edu

Courses:

  • BIO 321 Physiology
  • BIO 329 Principles of Pharmacology
  • BIO 493 Integrative Pharmacology
  • BIO 499 Integrative Biomedicine and Disease
  • BIO 513 Advanced Topics in Cell Physiology

Research: The physiological and molecular regulation of the intracellular signaling that contribute to cardiovascular diseases.  

Dr. Banes-Berceli is currently investigating hypertension and the renal and vascular complications of diabetes. Her research projects involve using a combination of an in vivo physiological approach as well as a molecular approach. The following research projects are currently in progress:

  1. ANG II and JAK2 interactions in hypertension
  2. Regulation of protein phosphatases which control the JAK/STAT in vivo
  3. Mechanisms of serotonin's interaction with angiotensin II and ET-1
Selected publications:

Banes-Berceli, A.K., Al-Azawi, H., Proctor, D., Qu, H., Femminineo, D., Hill-Pyror, C., Webb, R.C., Brands, M.B. (2011)  Angiotensin II utilized Janus Kinase 2 in hypertension bu not in the physiologic control of blood pressure during low salt intake. Am J Physiol Regul Integr Comp Physiol. 301:  R1169-1176.

Chiasson, V.L, Talreja, D., Young, K.J., Chatterjee, P., Banes-Berceli, A.K., Mitchell, B.M. (2011)  FK506 binding protein 12 deficiency in endothelial and hematopoetic cells decreases regulatory T cells and causes hypertension. Hypertension 57: 1167-1175. 

Brands, M.W., Banes-Berceli, A.K., Al-Azawi, H., Allen, A.J., Inscho, E., Labazi, H. (2010)  Interleukin-6 knockout prevents angiotensin II hypertension: Role of renal vasoconstriction and JAK2/STAT3 activation. Hypertension 56: 879-884.

Banes-Berceli, A.K., Ketsawatsomkron, P., Ogbi, S., Patel, B., Pollock, D.M., Marrero, M.B. ( 2007)  Angiotensin II (ANG II) and Endothelin-1 (ET-1) augment the vascular complications of diabetes via JAK2. Am J Physiol Heart and Circ Physiol. 293: 1291-1299.

Marrero, M.B., Banes-Berceli, A.K., Stern, D.M., Eaton, D.C. (2006)  Role of JAK/STAT signaling pathway in diabetic nephropathy. Am J Physiol Renal Physiol 290: F762- F768.

Banes-Berceli, A.K., Shaw, S., Ma, G., Ogbi, S., Shirley, A., Caldwell, R.W., Stern, D.M., Fulton, D., Marrero, M.B. (2006)  Effect of simvastatin on high glucose-and angiotensin II-induced activation of the JAK/STAT pathway in mesangial cells. Am J Physiol Renal Physiol. 291:  F116-121.

Banes, A.K., Shaw, S., Tawfik, A., Patel, B., Ogbi, S., Fulton, D., Marrero, M.B. (2005) Activation of the JAK/STAT pathway in vascular smooth muscle by serotonin is independent of reactive oxygen species. Am J Physiol Cell Physiol. 288: 805-812.

Banes-Berceli, A.K., Ogbi, S., Tawfik, A., Patel, B., Shirley, A., Pollock, D.M., Fulton, D., Marrero, M.B. (2005)  Activation of the JAK/STAT pathway by endothelin-1 in vascular smooth muscle: in vivo and in vitro evidence of the involvement of NAD(P)H -derived reactive oxygen species. J Vasc Pharmacol 43: 310-319, 2005.

Tawfik, A., Jin, L., Banes-Berceli, A.K. , Caldwell, R.B., Ogbi, S., Shirley, A., Barber, D., Catravas, J.D., Stern, D.M., Fulton, D., Caldwell, R.W., and Marrero, M.B. (2005)  Hyperglycemia-induced reactive oxygen species mediates apoptosis in aortic endothelial cells through Janus Kinase 2. J Vasc Pharmacol 43: 320-326.